Genmab Ofatumumab - Human Monoclonal Antibody
Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.
-
Most popular related searches
Details
Indication and Safety
Ofatumumab is approved in the U.S. as Kesimpta® for the treatment of relapsing multiple sclerosis (RMS) in adults, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It is the first B-cell therapy that can be self-administered at home by patients using a Sensoready® autoinjector pen.
Customer reviews
No reviews were found for Genmab Ofatumumab - Human Monoclonal Antibody. Be the first to review!